Geode Capital Management, LLC Concert Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.34 - $5.84 $40,661 - $54,714	9,369 Added 2.29%	417,858 $2.44 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $700,775 - $1.18 Million	164,116 Added 67.16%	408,489 $2.74 Million
Q2 2022 Aug 12, 2022	SELL	$2.8 - $6.36 $24,670 - $56,037	-8,811 Reduced 3.48%	244,373 $1.03 Million
Q1 2022 May 13, 2022	SELL	$2.73 - $3.94 $10,808 - $15,598	-3,959 Reduced 1.54%	253,184 $853,000
Q4 2021 Feb 11, 2022	SELL	$2.69 - $4.22 $232,838 - $365,270	-86,557 Reduced 25.18%	257,143 $810,000
Q3 2021 Nov 12, 2021	BUY	$3.17 - $4.15 $73,157 - $95,773	23,078 Added 7.2%	343,700 $1.12 Million
Q2 2021 Aug 13, 2021	SELL	$3.77 - $5.24 $821,479 - $1.14 Million	-217,899 Reduced 40.46%	320,622 $1.35 Million
Q1 2021 May 12, 2021	BUY	$4.86 - $13.07 $763,768 - $2.05 Million	157,154 Added 41.21%	538,521 $2.69 Million
Q4 2020 Feb 12, 2021	BUY	$9.48 - $12.84 $152,154 - $206,082	16,050 Added 4.39%	381,367 $4.82 Million
Q3 2020 Nov 13, 2020	BUY	$8.67 - $10.82 $72,862 - $90,931	8,404 Added 2.35%	365,317 $3.59 Million
Q2 2020 Aug 13, 2020	BUY	$7.8 - $11.52 $153,137 - $226,172	19,633 Added 5.82%	356,913 $3.55 Million
Q1 2020 May 14, 2020	BUY	$5.98 - $13.09 $441,204 - $965,780	73,780 Added 28.0%	337,280 $2.98 Million
Q4 2019 Feb 13, 2020	BUY	$5.71 - $9.22 $101,272 - $163,525	17,736 Added 7.22%	263,500 $2.43 Million
Q3 2019 Nov 12, 2019	BUY	$5.88 - $12.35 $2,334 - $4,902	397 Added 0.16%	245,764 $1.45 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $172,553 - $239,820	18,279 Added 8.05%	245,367 $2.94 Million
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $237,670 - $345,380	19,691 Added 9.49%	227,088 $2.74 Million
Q4 2018 Feb 13, 2019	SELL	$11.25 - $16.17 $217,878 - $313,164	-19,367 Reduced 8.54%	207,397 $2.6 Million
Q3 2018 Nov 13, 2018	BUY	$12.82 - $17.88 $307,885 - $429,406	24,016 Added 11.85%	226,764 $3.37 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $318,978 - $410,521	18,953 Added 10.31%	202,748 $3.41 Million
Q1 2018 May 15, 2018	BUY	$19.24 - $28.03 $311,899 - $454,394	16,211 Added 9.67%	183,795 $4.21 Million
Q4 2017 Feb 13, 2018	BUY	$13.96 - $29.05 $516,268 - $1.07 Million	36,982 Added 28.32%	167,584 $4.33 Million
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $33,662 - $37,050	2,420 Added 1.89%	130,602 $1.93 Million
Q2 2017 Aug 14, 2017	BUY	N/A	128,182	128,182 $1.79 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account